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SpAnX-A/D protein subfamily plays 
a key role in nuclear organisation, 
metabolism and flagellar motility  
of human spermatozoa
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iraia Muñoa-Hoyos1,2, Marta Gianzo1, Jose Antonio Rodriguez5, teresa Ganzabal6, 
Blagoy Blagoev4, irina Kratchmarova4,7* & nerea Subiran  1,2,7*
Human sperm protein associated with the nucleus on the X chromosome (SpAnX) genes encode a 
protein family (SpAnX-A, -B, -c and -D), whose expression is limited to the testis and spermatozoa 
in normal tissues and to a wide variety of tumour cells. present only in hominids, SpAnX-A/D is 
exclusively expressed in post-meiotic spermatids and mature spermatozoa. However, the biological 
role of the protein family in human spermatozoa is largely unknown. combining proteomics and 
molecular approaches, the present work describes the presence of all isoforms of SpAnX-A/D in human 
spermatozoa and novel phosphorylation sites of this protein family. In addition, we identify 307 
potential SpAnX-A/D interactors related to nuclear envelop, chromatin organisation, metabolism and 
cilia movement. Specifically, SPANX-A/D interacts with fumarate hydratase and colocalises with both 
fumarate hydratase and Tektin 1 proteins, involved in meeting energy demands for sperm motility, 
and with nuclear pore complex nucleoporins. We provide insights into the molecular features of sperm 
physiology describing for the first time a multifunctional role of SPANX-A/D protein family in nuclear 
envelope, sperm movement and metabolism, considered key functions for human spermatozoa. 
SpAnX-A/D family members, therefore, might be promising targets for sperm fertility management.
Currently, over 186 million people worldwide have infertility problems1, and male factors represent approxi-
mately 40–50% of clinical infertility cases2. Among other factors, anatomical or genetic abnormalities, problems 
in spermatogenesis or environmental factors3, are responsible for abnormal sperm parameters which contribute 
to male infertility. However, approximately 20–30% of men with normal sperm parameters have impaired fertility 
suggesting that male infertility can be caused by different deficiencies not yet described.
The sperm protein associated with the nucleus mapped to the X chromosome (SPANX) family is a 
testis-specific multigene family. SPANX genes encode proteins that belong to the so-called “cancer testis anti-
gens” (CTA) family, a group of proteins whose expression is limited to the testis and spermatozoa in normal 
tissues and to a wide variety of tumours4,5. The SPANX family includes two subfamilies: the SPANX-N subfamily, 
composed of SPANX-N1, -N2, -N3, -N4 (in the locus Xq27.3) and -N5 (in the locus Xp11.22) that share a high 
level of sequence homology6; and the SPANX-A/D subfamily, which includes SPANX-A1, -A2, -C, -D (in the 
locus Xq27.2) and –B (in the locus Xq27.1) with high sequence homology5,7. Evolved from a common ancestor, 
the SPANX-N gene family is present in mice, rats and all primates, while the SPANX-A/D family is expressed only 
in hominids, including humans, bonobos and chimpanzees8. All SPANX proteins exhibit a similar post-meiotic 
expression pattern during spermatogenesis, appearing for the first time in haploid spermatids4,7,9. In mature sper-
matozoa, SPANX-N proteins are localised on the acrosome6, while SPANX-A/D proteins are expressed as dots 
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in the cytoplasm and nucleus4. This difference in localisation could imply different roles for each subfamily in 
mature spermatozoa. Interestingly, the biological function of the SPANX-A/D family is still largely unknown.
Combining proteomics and molecular approaches, our aim was to elucidate the biological function of the 
SPANX-A/D subfamily in mature human spermatozoa. Our results describe for the first time a multifunctional 
role of SPANX-A/D in several key functions of human spermatozoa such as nuclear organization, metabolism 
and cilium movement.
Results
characterisation of SpAnX-A/D protein expression, phosphorylation and localisation in human 
spermatozoa. The SPANX multigene family has been previously well characterised at the gene level6,10. 
To shed light on the role of the SPANX-A/D subfamily in human spermatozoa, we first carried out the sub-
family characterisation at the protein level. Using immunoblotting, we evaluated the expression of endog-
enous SPANX-A/D in both soluble and insoluble protein fractions of human spermatozoa in 5 independent 
biological samples from normozoospermic patients. The anti-SPANX polyclonal antibody labelled two (37 kDa 
and 20 kDa) and three bands (50 kDa, 37 kDa and 20 kDa) in the soluble and insoluble fractions, respectively 
(Fig. 1A). No immunoreactivity was observed when the primary antibody was omitted (data not shown). We 
next determined the localisation of SPANX-A/D in human spermatozoa in normozoospermic samples (n = 4) 
Figure 1. Characterisation of SPANX-A/D in human spermatozoa (A) Immunoblotting of SPANX-A/D 
protein in soluble and insoluble protein fractions (N = 5) (B) Immunofluorescence of SPANX-A/D protein in 
human spermatozoa. Negative controls were performed by omitting the primary antibody before secondary 
antiserum addition. Nuclei were stained with Hoechst and are represented in blue. Scale bar 5 μm (N = 4). (C) 
Immunoblotting of SPANX-A/D protein family in fertile (normozoospermic samples; F1: 750.000 cells; F2: 
500.000 cells) and infertile (oligoteratoastenozoospermic sample; I:500.000 cells) patients. Tubulin was used as 
loading control. Representative image form 3 independent oligoteratoasthenozoospermic samples. (D) Table 
containing the unique peptides corresponding to each SPANX-A/D isoform found by LC-MS/MS in human 
spermatozoa. Comparison of each SPANX isoform sequence; each colour corresponds to the different peptides 
found by mass spectrometry. (E) Phosphorylation sites of each SPANX-A/D isoform found by LC-MS/MS are 
represented in yellow. The tree overlapping consensus NLSs are indicated in boxes.
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by immunofluorescence. These studies confirmed the presence of SPANX-A/D proteins in human sperm cells 
(Fig. 1B). Strong immunoreactivity was observed at the neck of spermatozoa (60% of the SPANX-A/D-positive 
cells), on the acrosome (30% of the SPANX-A/D-positive cells) and in the nucleus (10% of the SPANX-A/D-
positive cells), specifically in nuclear vacuoles (Fig. 1B). In addition, immunoreactivity was detected along the 
tail in 100% of the spermatozoa. No fluorescent staining was observed when the primary antibody was omitted.
In order to evaluate a potential role of SPANX-A/D in human sperm fertility, we measured its protein levels 
in normal (normozoospermia) and infertile men (oligoteratoasthenozoospermia), in which the concentration of 
sperm cells is reduced to less than 15 × 106/ml, the sperm cell shape is abnormal and the sperm motility is dimin-
ished by over 40%. Western blot experiments performed with a small cohort of infertile patients (n = 3), showed a 
decreased SPANX-A/D protein levels in oligoteratoasthenozoospermic samples compared to normozoospermic 
semen (Fig. 1C).
Due to the high amino acid sequence homology among the members of the SPANX-A/D family4, we were 
not able to distinguish the different SPANX-A/D isoforms using commercially available polyclonal antibodies. 
Therefore, to circumvent this limitation, the presence of SPANX-A/D isoforms was evaluated by mass spectrom-
etry (LC/MS-MS) in 10 normozoospermic samples and three technical replicates. In addition to common pep-
tides shared by all isoforms, unique peptides belonging to SPANX -A, -B, -C and -D were detected by LC-MS/
MS (Fig. 1D), proving the presence of all SPANX-A/D family members in humans. Of note, one of the identi-
fied common peptide (TSESSTILVVRYR) overlaps a putative nuclear localisation signal (NLS) that has been 
previously described for this protein subfamily4,11. Additionally, LC-MS/MS analyses were performed to search 
for phosphorylation sites on SPANX-A/D family members. Following the strict criteria described in Materials 
and Methods, we identified a total of 7 unique phosphorylation sites on SPANX-A/D family members (Fig. 1E). 
Specifically, seven phosphorylated residues were detected in SPANX-A (Ser5, Ser13, Ser18, Thr28, Ser47, Ser48 and 
Thr49), six in SPANX-B (Ser5, Ser13, Ser18, Ser53, Ser54 and Thr55) and four in SPANX-C/-D (Ser5, Ser47, Ser48 and 
Thr49). In addition, Ser47, Ser48, and Thr49 (corresponding to Ser53, Ser54 and Thr55 of SPANX-B) are located within 
the NLS of this protein family. Remarkably, we described for the first time those novel phosphorylation sites of 
SPANX-A/D protein subfamily members in human spermatozoa in vivo, since there are no previous evidences 
regarding these residues in PhosphoSitePlus database12.
characterisation of novel SpAnX-A/D phosphosites. Considering that several SPANX-A/D phos-
phosites were located on a putative NLS, we evaluated their role on nuclear translocation. We used phospho-
mimetic approaches and transfection of YFP-tagged proteins to determine whether the phosphorylation state 
of SPANX-A/D influenced the nuclear translocation of SPANX-A/D (Fig. 2A). Due to the impossibility of per-
forming transfections in human spermatozoa, we performed these experiments in HeLa and HEK293T cell lines. 
First, we evaluated the functionality of the putative NLS using NLS-null SPANX mutants (YFP-NLSDEL) (Fig. 2B 
and Supplementary Fig. 1A). YFP-SPANX-A exhibited prominent nuclear localisation, accumulating in nuclear 
dots and in the periphery of the nucleus. In contrast, the YFP-NLSDEL mutant was diffusely localised throughout 
the cell (Fig. 2B and Supplementary Fig. 1A), indicating that the NLS is required for the nuclear accumulation of 
SPANX-A. Of note, the NLS sequences of SPANX-A/-B and SPANX-C/-D differ at a single amino acid position. 
To evaluate whether this specific amino acid difference affects NLS functionality, we designed two different con-
structs encoding the NLS with either a leucine (YFP-NLSLEU) or a methionine (YFP-NLSMET) residue (Fig. 2A). 
Both constructs led to similar nuclear localisation of the YFP-tagged proteins (Fig. 2C and Supplementary 
Fig. 1B), suggesting that the leucine/methionine sequence variation does not significantly affect the NLS func-
tionality. Then, to evaluate whether the difference in length between SPANX-A and SPANX-B, which is 6 amino 
acids longer than SPANX-A, correlates with a different subcellular distribution; we designed a construct encoding 
YFP-SPANX-B. Both YFP-SPANX-A and YFP-SPANX-B exhibited similar nuclear localisation in both cell lines 
(Fig. 2D and Supplementary Fig. 1C). In fact, a 3D reconstruction (Supplementary Fig. 2) revealed that both 
constructs were organised in nuclear dots of variable size showing the presence of larger dots localised inside 
the nucleus and smaller dots with epinuclear localisation along the nuclear envelope. Finally, phosphomimetic 
approaches were used to replace the three phosphosites inside the NLS (Ser47, Ser48 and Thr49) with aspartic 
acid (D) or alanine (A), mimicking the phosphorylated (YFP-NLSPM) and non-phosphorylated (YFP-NLSN-PM) 
states of the NLS, respectively. We detected no significant difference in the localisation of the wild-type (WT), 
YFP-NLSPM and YFP-NLSN-PM constructs (Fig. 2E and Supplementary Fig. 1D). Therefore, we next replaced all 
the phosphosites identified in SPANX-A/D (Ser5, Ser13, Ser18, Thr28, Ser47, Ser48 and Thr49) with aspartic acid or 
alanine to mimic the phosphorylated (YFP-SPANX-APM) and non-phosphorylated (YFP-SPANX-AN-PM) versions 
of the protein (Fig. 2A), respectively. Both constructs were able to translocate into the nucleus of HeLa (Fig. 2F) 
and HEK293T (Supplementary Fig. 1E) cells and accumulated in nuclear dots, indicating that the phosphoryl-
ation state is not a crucial determinant of the nuclear translocation of the protein. Nevertheless, the phosphom-
imetic YFP-SPANX-APM mutant showed larger and more intense dots inside the nuclei of HeLa and HEK293T 
cells than WT or non-phosphorylated mutant (Fig. 2F,G and Supplementary Fig. 1E,F), suggesting that the phos-
phorylation state of the protein might influence SPANX-A/D protein complex stabilisation.
functional characterisation of the SpAnX-A/D protein family in human spermatozoa. To 
uncover the physiological role of the SPANX-A/D subfamily in human normozoospermic spermatozoa, we stud-
ied the interactome using a label-free quantitative proteomics approach. Considering that nearly 30% of the 
proteins expressed in human spermatozoa are cell-specific and not found in any other cell types, we searched 
for SPANX-A/D interactors in human spermatozoa using the endogenous SPANX-A/D protein family as 
bait (Fig. 3A and Supplementary Fig. 3). SPANX-A/D proteins from a pool of 80 normozoospermic samples 
were immunoprecipitated with the polyclonal commercial anti-SPANX antibody (Abcam, ab119280) and 
co-precipitating proteins were digested in solution with trypsin to be analysed by LC-MS/MS in 4 technical 
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replicates. A non-specific rabbit IgG that does not bind SPANX-A/D was used as a negative control in parallel 
pull-down assays. A total of 307 potential SPANX-A/D interactors were identified. We considered as potential 
SPANX-A/D interactors those proteins that were confidently detected in the four SPANX-A/D pulldowns but in 
not in the negative control pull-down assays (Supplementary Table S1). Gene ontology (GO) analysis (Fig. 3B) 
revealed that potential SPANX-A/D interactors are mainly involved in nuclear pore organisation (23.65-fold 
enrichment), cilium or flagellum-dependent motility (23.65-fold enrichment), assembly of the axonemal dynein 
complex (16.02-fold enrichment) and mitochondrial electron transport (11.58-fold enrichment). These results 
suggest that the SPANX-A/D protein subfamily may exert a multifunctional role in human spermatozoa. A 
more in-depth analysis (Fig. 3C,D) revealed that several nuclear proteins, such as testis-specific H1 histone 
(H1FNT) or histone 1 (HISTH1T); chromatin regulators, such as SET domain-containing protein 9 (SETD9) 
or histone deacetylase 11 (HADC11); and nucleoporins (NUPs), such as NUP98, NUP93, NUP35 or NUP188, 
co-precipitated with SPANX-A/D. Specifically, NUP98 co-localised with SPANX-A/D in the neck of the sperma-
tozoon (Fig. 3E). On the other hand, the structural component of cilia and flagellar microtubules, such as dyneins 
and tektins, also co-precipitated with SPANX-A/D. TEKT1 co-localised with the protein family in the neck of 
the spermatozoa and along the tail (Fig. 3E). Finally, proteins related to mitochondrial metabolic processes, such 
as fumarate hydratase (FH) that showed the highest MS intensity, NADH dehydrogenase alpha subcomplex 
assembly factor (NDUFAF2), and mitochondrial ATP synthase subunit epsilon (ATP5E) (Fig. 3C,D) were also 
Figure 2. Mutagenesis studies of the SPANX-A/D protein subfamily in HeLa cells. (A) Schematic 
representation of all mutants transfected in HeLa cells. All expression plasmids were expressed with a YFP tail. 
YFP-SPANX-A was used as a wild-type sequence. The NLS appears drawn in yellow within the sequence of 
each YFP-mutant. Confocal microscopy images showing representative examples of HeLa cells transfected with 
expression plasmids encoding (B) YFP (vector), WT and WT mutant with deleted NLS (YFP-NLSDEL) (63×). 
DAPI was used to counterstain the nucleus (DNA panels) (N = 3); (C) YFP, the NLS of WT with methionine 
(YFP-NLSMET) and leucine (YFP-NLSLEU) at the 42nd position of the sequence (63×) (N = 3); (D) YFP, YFP-
SPANX-A (WT) and YFP-SPANX-B (63×) (N = 3). Confocal images of phosphomimetic (YFP-NLSPM) and 
dephosphomimetic mutants (YFP-NLSN-PM) of NLS at the 47th, 48th and 49th positions (63×) (N = 3); (F) 
Confocal images of phosphomimetic (YFP-SPANX-APM) and dephosphomimetic mutants (YFP-SPANX-
AN-PM) of the SPANX-A, modifying all identified phosphosites at the 5th, 13th, 18th, 28th, 47th, 48th and 49th 
positions of the protein sequence (40x and 63×). The zoomed section appears framed by a dotted line. DAPI 
was used to stain the nuclei (DNA panels). Scale bar: 15 μm. (N = 3) (G) Graph showing the corrected total cell 
fluorescence (CTCF) intensity/YFP positive cells of the YFP-SPANX-APM vs YFP-SPANX-AN-PM mutants. The 
data shown in the graph correspond to the mean of three independent experiments, and the error bars indicate 
the SEM. *P < 0.05 (Student’s t-test).
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identified as potential SPANX-A/D interactors. Specifically, FH co-localised with SPANX-A/D in the neck of the 
spermatozoon (Fig. 3E) and physical interaction between both proteins FH and SPANX-A/D in human sperma-
tozoa was confirmed by co-immunoprecipitation assays (Fig. 3F and Supplementary Fig. 3).
Discussion
SPANX-A/D is a multigene family mapped on the X chromosome exhibiting testis-specific expression and 
mRNA/protein localisation exclusively in post-meiotic spermatids5,11. The presence of the SPANX-A/D subfamily 
has been widely studied in a broad variety of cancer types over the last twenty years4,10,13. In 2001, these proteins 
were described for the first time in testis and spermatozoa4; however, the biological role in sperm fertility is largely 
unknown. Through a combination of proteomic analysis, phosphomimetic assays and molecular approaches, our 
results indicate that SPANX-A/D is a multifunctional protein family that may play a key role in human sperm 
physiology (Fig. 4). In line with other studies4,9,11, we confirmed the presence of all isoforms of the SPANX-A/D 
subfamily protein, which are localised in the nucleus, cytoplasm and in the flagellum of human spermatozoa. 
Specifically, SPANX-A/D is located at the nuclear vacuoles of human spermatozoa, which are known to be related 
to sperm genome instability and, therefore, to sperm fertility14. In fact, although further studies are needed to 
confirm this fact in a larger cohort of patients, our results suggest that SPANX-A/D protein levels are lower in 
infertile men with oligoteratoasthenozoospermia than in fertile men. This is consistent with the fact that asthe-
nozoospermic semen samples present a lower expression of SPANX-B at protein levels than normozoospermic 
samples15, suggesting that the presence of SPANX-A/D in mature spermatozoa may be crucial for the mainte-
nance of human sperm functions.
Figure 3. Study of the SPANX-A/D interactome in human spermatozoa. (A) Immunoprecipitation of SPANX-
A/D in human spermatozoa. (N = 3) (B) GO analysis based on the biological functions of co-precipitated 
proteins together with SPANX-A/D in human spermatozoa. The twenty most enriched processes are shown. 
P < 0.05. (C) Representative scheme of principal interactors of SPANX-A/D based on their localisation in 
human spermatozoa and biological function. Only the 45 most intense interactors with no enriched biological 
function are shown. (D) Schematic representation of the 15 most intense interactors of each biological process. 
The size of the nodes and the thickness of the edges represent the intensity of each potential interactor. (E) Co-
localisation assays by immunocytochemistry of SPANX-A/D (green) and NUP98, TEKT1 and FH (red). For the 
specificity of the secondary antisera, the primary antibodies were omitted. The nuclei were stained with Hoechst 
and are represented in blue. The transmitted image of human sperm is included to show the integrity of the 
sample. Scale bar: 2 μm. (N = 3) (F) Co-immunoprecipitation of SPANX-A/D and FH. Negative controls were 
performed with non-specific IgG antibodies for immunoprecipitation.
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On the other hand, we describes for the first time novel SPANX-A/D phosphorylated residues in normal 
human spermatozoa in vivo, in spite of some phosphosites have been previously reported in different cancer cell 
types (PhosphoSitePlus database 11076738, 11076741, 9161501, 50832232, 11076732, and 11076735). Proteomic 
approaches reveal the presence of seven novel phosphosites along the SPANX-A/D protein sequences (Ser5, 
Ser13, Ser18, Thr28, Ser47, Ser48, and Thr49) and, interestingly, three of them lie within the NLS. In order to eval-
uate its potential role in cytoplasm-nuclear transport, we carried out phosphomimetic analyses. The phospho-
rylation state of neither the NLS nor the whole protein is determinant of SPANX-A nuclear translocation, but 
this post-translational modification may be important for promoting the stabilisation of the SPANX-A dots into 
nucleoplasm.
Taking into account the widespread localisation of SPANX-A/D, this protein family might play different roles 
in human spermatozoa. Since the expression of the SPANX-A/D subfamily appears to be restricted to hominids7, 
knockout mice are not useful models for elucidating its biological function. Importantly, human spermatozoa 
present a unique proteome, and at least 30% of this proteome is made up of sperm-specific proteins16. Therefore, 
in an attempt to clarify the physiological role of the protein family, we carried out an interactome analysis of 
endogenous SPANX-A/D protein family in human spermatozoa from normozoospermic samples, using it as 
bait in immunoprecipitation assays. Our results indicate that SPANX-A/D protein family plays a multifunctional 
role in human spermatozoa. We have identified 307 proteins related to nuclear envelope and chromatin organisa-
tion, mitochondrial metabolism and flagellum-dependent motility that co-immunoprecipitate with SPANX-A/D. 
According to the interactome analysis, SPANX-A/D co-precipitates with several components of the nuclear pore 
complex such as NUP98, NUP93, NUP35 and NUP188. Our results, together with the fact that previous studies 
localise SPANX-A/D in nuclear envelope organisation4, indicate that SPANX-A/D might be part of nuclear pore 
envelope. SPANX-A/D and NUP98 co-localise in the neck of spermatozoa, which is considered a redundant 
nuclear envelope in mature spermatozoa17. Besides nucleocytoplasmic transport regulation, nuclear pore com-
plexes directly interact with chromatin to regulate transcription17. Interactome approach also identifies proteins 
involved in chromatin regulation as potential SPANX-A/D interactors such as several histones (testis-specific 
H1 histone (H1FNT) and histone 1 (HISTH1T)) and chromatin regulators (SET domain-containing protein 9 
(SETD9) and histone deacetylase 11 (HADC11)). This is consistent with the fact that SPANX-A/D protein family 
is present inside nuclear vacuoles, which have been widely associated with chromatin condensation failure and 
genomic instability18–20,. Therefore, our results indicate that SPANX-A/D might play an important role in sperm 
physiology by regulating chromatin organisation in mature spermatozoa.
Additionally, SPANX-A/D subfamily also co-precipitates with proteins involved in other physiological func-
tions related to mitochondrial metabolism such as FH, cilium organisation and flagellum-dependent motility 
such as tektins and dyneins. The contribution of the metabolic/energy pathways in sperm motility has been pre-
viously reported since the beat frequency of the flagellum is directly related to the production rate of energy 
from ATP21–24. The axonemal dyneins generate force through the hydrolysis of the ATP created in the mitochon-
dria and bind to the structural components of the mictubules, such as tektins, to actively participate in flagellar 
movement25. In line with this fact, the expression of FH and TEKT1 is lower in semen samples with poor sperm 
motility (asthenozoospermia)26, indicating that SPANX-A/D family, through the interaction with both proteins 
FH and TEKT1, could be essential in human spermatozoa to meet energy demands for motility.
Overall, a more detailed knowledge of the biological role of the SPANX-A/D protein family is indispensable 
for understanding human sperm fertility and may be useful for elucidating the aetiology of many cases of male 
infertility. Although further studies need to be performed in order to evaluate the role of each isoform in human 
spermatozoa, SPANX-A/D protein family may be a promising target for sperm fertility management in humans 
as it plays a multifunctional role in nuclear envelope, sperm movement and metabolism.
Methods
Samples and isolation of spermatozoa. Ethical approval for this study was obtained from the Ethics 
Committee of the University of the Basque Country (CEISH-UPV/EHU (M10/2016/254)), and all experiments 
were performed in accordance with relevant guidelines and regulations. Informed consent was also obtained 
from all participants. Freshly ejaculated semen was collected from 112 men undergoing routine semen analysis 
at the Center for Reproductive Medicine and Infertility Quirón (Bilbao, Spain). The men had normal sperm 
Figure 4. Role of SPANX-A/D in human spermatozoa. Schematic representation of molecular mechanisms in 
which SPANX-A/D is involved in human spermatozoa. Physical interactions are represented with a continuous 
line, while the co-expression is shown with a discontinuous line.
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parameters (normozoospermia) according to World Health Organization standards27. The infertile spermatozoa 
corresponded to 3 different oligoteratoasthenozoospermic samples (the concentration of sperm cells is reduced to 
less than 15 × 106/ml, their motility is diminished by over 40% and have abnormal sperm shape27). Semen sam-
ples were obtained by masturbation after 3–4 days of sexual abstinence and processed immediately upon lique-
faction (at 37 °C for 30 min). Spermatozoa were capacitated by the swim-up procedure and resuspended in G-IVF 
(Vitrolife, Goteborg, Sweden) supplemented with 1% bovine serum albumin for 3 h at 37 °C under 5% CO2.
plasmids, cloning procedures and mutagenesis. Locus position of SPANX-A/D is described by 
Kouprina et al.7. To generate the plasmids encoding YFP–SPANX-A (WT), YFP-SPANX-B, YFP-SPANX-A-NLS 
Deleted (YFP-NLSDEL), YFP-NLSMET, YFP-NLSLEU, YFP-NLSPM, YFP-NLSN-PM, YFP-SPANX-APM and YFP- 
SPANX-AN-PM, each cDNA was synthetised as HindIII/BamHI fragments (gBlocks Gene Fragments, Integrated 
DNA Technologies, CA, USA) and subcloned into pEYFP-C1 plasmids (Clontech, Mountain View, CA, USA). All 
of the constructs generated were subjected to DNA sequencing (Stabvida, Caparica, Portugal), and the absence of 
any unwanted mutation was confirmed. The sequences of the oligonucleotides used in cloning and mutagenesis 
are available upon request. The amino acid sequences coding each YFP protein are detailed below in Fig. 2A.
transfections and confocal microscopy. HeLa cells (human epithelial cervical cancer cells) and 
HEK293T cells (human epidermal kidney cells) were cultured in Dulbecco’s modified Eagle’s medium sup-
plemented with 10% FBS, 2 mM L-Glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin (all from 
Invitrogen, Carlsbad, CA, USA). Twenty-four hours before transfection, the cells were seeded onto 12-well 
or 6-well tissue culture plates. HEK293T and HeLa cell line plasmid transfections were carried out with 
X-tremeGENE 9 transfection reagent (Roche Diagnostics, Indianapolis, IN, USA) according to the manufactur-
er’s protocol. To evaluate the transfection efficiency, cells growing on sterile coverslips were fixed with 3.7% for-
maldehyde in PBS for 30 min and then assembled onto slides using Vectashield Antifade Mounting Medium with 
DAPI (Vector Laboratories, USA). To avoid bias in the quantification of YFP fluorescence, slides were encoded, 
and images were taken and examined unaware of the identity of the samples. Image analysis with ImageJ software 
was used to quantify the intensity of YFP fluorescence.
Western blotting. For protein expression analyses, isolated sperm cells were lysed using ice-cold RIPA 
buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% NP-40, 1 mM EDTA, 0.25% sodium deoxycholate, 1 mM 
sodium pervanadate, 5 mM beta-glycerophosphate, 5 mM NaF, complete protease inhibitor cocktail (Complete 
tablets, Roche)). After protein homogenisation and sonication (20% amplitude, 10 pulses, three times, Labsonic 
B.Braun International), proteins were separated both in soluble and insoluble fractions by centrifugation at 
13000 g, 4 °C, 15 min. The protein concentration was measured by the Bicinchoninic Acid (BCA) assay method.
For the characterisation on SPANX-A/D protein family in human spermatozoa, thirty micrograms of each 
insoluble and soluble protein fraction were prepared. For the comparison of SPANX-A/D protein levels in nor-
mozoospermic and infertile spermatozoa, fifty and thirty micrograms of insoluble protein fraction were pre-
pared. Protein extracts were diluted in Laemmli sample buffer containing dithiothreitol (DTT) and were boiled 
for 5 min. All samples were loaded onto 12% resolving gels and separated by one-dimensional sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
Proteins were then transferred to polyvinylidene fluoride membranes using the Mini Trans-Blot 
Electrophoretic Transfer System (Bio-Rad Laboratories, Hercules, CA, USA). After transfer, the membranes 
were blocked with Blotto (20 mM Tris-HCl, pH 7.5, 0.15 M NaCl, and 1% Triton X- 100) containing 5% bovine 
serum albumin (BSA) (Sigma-Aldrich) for 1 h at room temperature and then incubated with a polyclonal rab-
bit anti-SPANX antibody (1:500) diluted in 5% BSA (ab119280, Abcam), a monoclonal mouse anti-tubulin 
antibody (1:10000) (T9026, Sigma-Aldrich) and a monoclonal mouse anti-FH antibody (sc-393992, Santa 
Cruz Biotechnology) (1:200). After washing in Blotto buffer, the membrane was incubated for 1 h with a 
peroxidase-conjugated goat anti-rabbit IgG antibody (1:1000) (goat anti-rabbit IgG-HRP, sc-2004, Santa Cruz 
Biotechnology) or a peroxidase-conjugated donkey anti-mouse IgG antibody (1:2000) (donkey anti-mouse 
IgG-HRP, sc-2314, Santa Cruz Biotechnology).
protein in-gel digestion. For the study of SPANX-A/D isoforms in human spermatozoa, the soluble and 
insoluble protein fractions were loaded onto a precast gradient NuPAGE 4–12% Bis-Tris Protein gel (Invitrogen) 
for further visualisation with Colloidal Blue (Invitrogen). Whole gel lines were cut into slices and subjected to 
reduction with 10 mM dithiothreitol (DTT), alkylation with 55 mM chloroacetamide (CAA) and protein diges-
tion by incubating with trypsin overnight at 37 °C. The resulting tryptic peptides were extracted from the gel by 
serial incubations with 100% acetonitrile (ACN) and 30% ACN/3% trifluoroacetic acid (TFA). Finally, the solu-
tions obtained in all the incubations were dried down in a vacuum centrifuge. Peptides derived from slices from 
each lane were concentrated and desalted using C18 stage tips (made in house using Empore Disc-C18 Agilent 
Life Science) for further analysis by LC-MS/MS.
immunoprecipitation and in-solution digestion. For the SPANX-A/D interactome in human sper-
matozoa, cells were lysed using commercial Co-IP buffer (Thermo Scientific) with complete protease and phos-
phatase inhibitor cocktail (Roche) (quadruplicate). After protein homogenisation and sonication (20% amplitude, 
10 pulses, three times), proteins were separated in soluble fractions by centrifugation at 13000 g and 4 °C for 
15 min. The soluble protein fraction was incubated for 4 h at 4 °C with magnetic beads (PureProteome Protein 
A Magnetic Beads, Millipore) conjugated to an anti-SPANX antibody (ab119280, Abcam). This polyclonal com-
mercial anti-SPANX antibody recognises an amino acid sequence (GDSDPQPAPKKMKTSE) corresponding to 
all SPANX-A, -B, -C and -D isoforms: As a negative control, rabbit IgGs (X0903, DAKO) were used at the same 
concentration as the antibody. Immune complexes were independently recovered and washed. Elution of the 
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immunocomplexes was carried out with 8 M guanidinium hydrochloride at pH 8 and 70 °C for 15 min. The pro-
teins were then reduced and alkylated, followed by in-solution digestion with LysC/trypsin. Peptides derived 
from each sample were concentrated and desalted using C18 stage tips (made in house using Empore Disc-C18 
Agilent Life Science) for analysis by LC-MS/MS.
Lc-MS/MS. Acidified peptide mixtures were separated by online C18 reverse-phase nanoscale liquid chroma-
tography and analysed by tandem mass spectrometry (LC-MS/MS). MS analysis was performed on a Q-Exactive 
HF mass spectrometer (Thermo Scientific, Bremen, Germany) connected to an EASY-nanoLC 1000 System 
(Thermo) using a nanoelectrospray ion source (Proxeon Biosystems, Odense, DK). Survey full-scan MS spectra 
(m/z range, 200–2000; resolution 60,000 at m/z 400) were acquired in the Orbitrap followed by the fragmentation 
of the twelve most intense multiply charged ions. Ions selected for MS/MS were placed on a dynamic exclusion 
list for 45 s. To improve mass accuracy, internal real-time lock mass calibration was enabled. Additional mass 
spectrometric parameters included a spray voltage of 2.3 kV, no sheath and auxiliary gas flow, and the tempera-
ture of the heated capillary was 275 °C. All raw files were searched against the combined human database 2015.08 
UniProt (with 42,122 sequence entries) and TrEMBL (with 49,496 sequence entries) using MaxQuant platform 
versions 1.5.2.8 and 1.5.3.30 with an Andromeda search engine. Precursor and fragment tolerances were 4.5 
and 20 ppm, respectively. A peak list was generated using the Quant element of MaxQuant using the follow-
ing parameters: a maximum of 2 missed cleavages were allowed, and enzyme specificity was set to trypsin. In 
addition, carbamidomethyl (C) was chosen as a fixed modification, and variable modifications included oxida-
tion (M), deamidation (NQ) and Phospho_STY (STY). The peptide and protein FDR 0.01; site FDR 0.01; max. 
peptide PEP, 1; min. peptide length, 7; and min. unique peptides and peptides, 1. For protein quantitation, only 
unmodified peptides and peptides modified by acetyl (protein N-terminus), oxidation (Met) and deamidation 
(NQ) were used. According to the protein group assignment performed by MaxQuant, the identified proteins 
were determined after removing the contaminants, reverse hits and proteins identified only by site. Moreover, 
we took into account those proteins with ≥2 identified peptides and ≥1 unique peptides. On the other hand, the 
phosphopeptide data were filtered by FDR < 1%, and only the phosphosites displaying a localisation probability 
above 0.75 were considered confident phosphorylated sites (Class I sites). Finally, the output data were analysed 
in the Perseus 1.6.0.7 bioinformatics analysis program.
Bioinformatics analysis. Perseus software (v.1.6.0.7) was employed for the calculation of the statistical sig-
nificance between the SPANX pull-down samples and the negative control in human spermatozoa. In the case of 
human spermatozoa, we filtered the protein list assuming as putative interactors those proteins identified with at 
least two peptides and containing a minimum of three unique peptides. The study was performed in quadrupli-
cate. Moreover, we accepted only those proteins that appeared in all four replicas of the SPANX-A/D immunopre-
cipitation samples but not in any of the negative controls as candidate proteins. The PANTHER (v13.1) functional 
annotation tool (http://geneontology.org/) was used to detect the overrepresented gene ontology (GO) term “bio-
logical process” within the possible SPANX interactors in human spermatozoa. The Cytoscape computational tool 
(v.3.5.1) was used for the visualisation of the SPANX-A/D interactome in human spermatozoa.
Indirect immunofluorescence and confocal microscopy. Isolated human sperm cells were fixed in 4% 
paraformaldehyde for 10 min, permeabilised in 0.5% Triton X-100 for 10 min and blocked for 30 min with 10% 
(v/v) foetal bovine serum (FBS) in PBS. For HEK293T and HeLa cell lines, however, permeabilisation was per-
formed using 0.2% Triton X- 100 for 10 min and blocking for 30 min with 10% (v/v) FBS in PBS. Then, the sam-
ples were incubated overnight at 4 °C with polyclonal rabbit anti-SPANX (ab119280, Abcam) (1:500), monoclonal 
mouse anti-NUP98 (sc-74578, Santa Cruz Biotechnology) (1:50), monoclonal mouse anti-TEKT1 (sc-398507, 
Santa Cruz Biotechnology) (1:50) and monoclonal mouse anti-FH (sc- 393992, Santa Cruz Biotechnology) 
(1:50) antibodies. Secondary antibody incubations included Alexa Fluor 488 donkey anti-rabbit IgG (1:2000) 
(Molecular Probes, Oregon USA), Alexa Fluor 555 goat anti-mouse IgG (1:1000) (Thermo Scientific) and Alexa 
Fluor 663 goat anti-rabbit IgG (1:1000) (Thermo Scientific) antibodies. Controls for the specificity of the second-
ary antisera were simultaneously performed by omitting the primary antiserum before addition of the secondary 
antiserum. Nuclei were stained with Hoechst 33258 at 10 µg/mL, and slides were assembled with Fluoromount 
G (Molecular Probes). Finally, the samples were examined using confocal microscopy (Zeiss Apotome 2, Jena, 
Germany) at the High-Resolution Microscopy Facility (SGIKER UPV/EHU). Image analysis was conducted 
using ImageJ software.
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